Inventor · disambiguated record
Hao Guo
Also filed as: GUO HAO · GUO HAO-BO
7 granted patents·8 pending applications·4 citations·filing 2012–2024
73Inventor score
Files withORICELL THERAPEUTICS CO LTD5UNIV SOUTHERN CALIFORNIA4UNIV NORTH CAROLINA CHAPEL HILL2BLANK LARS M1LI DAWEI1
Top patents by PatentIndex Score
15 records- 0181US11464867B2Multimeric elastin-like polypeptidesUNIV SOUTHERN CALIFORNIA·Filed 2019·Granted Oct 11, 2022·2 cites·6 claims
- 0273US12458704B2Multimeric elastin-like polypeptidesUNIV SOUTHERN CALIFORNIA·Filed 2022·Granted Nov 4, 2025·0 cites·18 claims
- 0365US9574012B2AGR2 blocking antibody and use thereofLI DAWEI·Filed 2012·Granted Feb 21, 2017·2 cites·17 claims
- 0463US2024400989A1Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 0555US2025297290A1Sequence for protein decayBLANK LARS M·Filed 2022·Application pending·0 cites
- 0654US11124559B2Generation of hemoglobin-based oxygen carriers using elastin-like polypeptidesUNIV SOUTHERN CALIFORNIA·Filed 2018·Granted Sep 21, 2021·0 cites·14 claims
- 0753US2022054561A1Lachnospiraceae mitigates against radiation-induced hematopoietic/gastrointestinal injury and death, and promotes cancer control by radiationUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 0851US11918621B2Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growthUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted Mar 5, 2024·0 cites·5 claims
- 0949US2024383992A1Bcma-targeting chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1048US2024366672A1Chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1145US10106807B2Transcription factor which regulates flavonoid, phenylpropanoid, tyrosine, and tryptophan pathwaysUT BATTELLE LLC·Filed 2015·Granted Oct 23, 2018·0 cites·3 claims
- 1241US2022389076A1Modified immune cell and use thereofORICELL THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1340US12005080B2Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2019·Granted Jun 11, 2024·0 cites·9 claims
- 1439US2017240651A1Agr2 blocking antibody and use thereofSANOFI (CHINA) INVEST CO LTD SHANGHAI BRANCH·Filed 2017·Application pending·0 cites
- 1538US2019022190A1Generation of hemoglobin-based oxygen carriers using elastin like polypeptidesUNIV SOUTHERN CALIFORNIA·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →